BioCentury
ARTICLE | Company News

GAL receives U.K. approval

April 9, 2001 7:00 AM UTC

Galen Holdings (LSE:GAL, GALN) received a U.K. license to market estradiol (estrogen) delivered using its intravaginal ring to relieve post-menopausal symptoms. The product will be submitted to the EU...